Value of fetuin‐A as a predictor of liver fibrosis in patients with nonalcoholic fatty liver disease

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 8, 2015-08 ,pp. : 2061-2061

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fetuin‐A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 3, 2015-03 ,pp. : 925-935

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: novel association between serum Pentraxin‐2 levels and advanced fibrosis in well‐characterised patients with non‐alcoholic fatty liver disease – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 6, 2015-09 ,pp. : 774-775

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nonalcoholic Steatohepatitis Score is an Independent Predictor of Right Ventricular Dysfunction in Patients with Nonalcoholic Fatty Liver Disease

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 5, 2015-10 ,pp. : 294-299

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use?

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 997-998

John Wiley & Sons Inc

Access to resources Recommend Favorite